Jpmorgan Chase & CO Avid Bioservices, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 108,684 shares of CDMO stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,684
Previous 28,376
283.01%
Holding current value
$1.33 Million
Previous $202,000
511.88%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CDMO
# of Institutions
183Shares Held
67.8MCall Options Held
89.9KPut Options Held
118K-
Black Rock Inc. New York, NY5.11MShares$62.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.19MShares$51.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.85MShares$47.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.82MShares$46.7 Million0.12% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.8MShares$46.5 Million4.48% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $762M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...